Naciye Sinem GEZER, Begüm ERGAN, Ali Necati GÖKMEN, Ali CANTÜRK, Bilgin CÖMERT, Mehmet Nuri YAKAR, Erdem YAKA, Murat KÜÇÜK, Bişar ERGÜN, Mahmut Cem ERGON

Clinical characteristics and risk factors for 28-day mortality in critically ill patients with COVID-19: a retrospective cohort study

Background: To date, the coronavirus disease 2019 (COVID-19) caused more than 2.6 million deaths all around the world. Risk factors for mortality remain unclear. The primary aim was to determine the independent risk factors for 28-day mortality. Materials and Methods: In this retrospective cohort study, critically ill patients (≥ 18 years) who were admitted to the intensive care unit due to COVID-19 were included. Patient characteristics, laboratory data, radiologic findings, treatments, and complications were analyzed in the study. Results: A total of 249 patients (median age 71, 69.1% male) were included in the study. 28-day mortality was 67.9% (n = 169). The median age of deceased patients was 75 (66–81). Of them, 68.6% were male. Cerebrovascular disease, dementia, chronic kidney disease, and malignancy were significantly higher in the deceased group. In the multivariate analysis, sepsis/septic shock (OR, 15.16, 95% CI, 3.96–58.11, p < 0.001), acute kidney injury (OR, 4.73, 95% CI, 1.55–14.46, p = 0.006), acute cardiac injury (OR, 9.76, 95% CI, 1.84–51.83, p = 0.007), and chest CT score higher than 15 (OR, 4.49, 95% CI, 1.51-13.38, p = 0.007) were independent risk factors for 28-day mortality. Conclusion: Early detection of the risk factors and the use of chest CT score might improve the outcomes in patients with COVID-19.Key words: COVID-19, critical care, tomography, mortality, risk factors, SARS-CoV-2

PDF

___

1. Huang C, Wang Y, Li X, Ren L, Zhao J et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395 (10223): 497–506. doi: 10.1016/ S0140-6736(20)30183-5
2. World Health Organization (2021). Coronavirus Disease (COVID-19) Dashboard [online]. Website https://covid19. who.int/ [accessed 11 April 2021].
3. Chidambaram V, Tun NL, Haque WZ, Majella MG, Sivakumar RK et al. Factors associated with disease severity and mortality among patients with COVID-19: A systematic review and meta-analysis. Public Library of Science One 2020; 15 (11): e0241541. doi: 10.1371/journal.pone.0241541
4. Giacomelli A, Ridolfo AL, Milazzo L, Oreni L, Bernacchia D et al. 30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: A prospective cohort study. Pharmacological Research 2020; 158: 104931. doi: 10.1016/j.phrs.2020.104931
5. Gupta S, Hayek SS, Wang W, Chan L, Mathews KS et al. Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US. Journal of the American Medical Association Internal Medicine 2020; 180 (11): 1436– 1447. doi: 10.1001/jamainternmed.2020.3596
6. COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators. Clinical characteristics and day90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study. Intensive Care Medicine 2021; 47 (1): 60–73. doi: 10.1007/s00134-020-06294-x
7. Liu J, Zhang S, Wu Z, Shang Y, Dong X et al. Clinical outcomes of COVID-19 in Wuhan, China: a large cohort study. Annals of Intensive Care 2020; 10 (1): 99. doi: 10.1186/s13613-020- 00706-3
8. Xie J, Wu W, Li S, Hu Y, Hu M et al. Clinical characteristics and outcomes of critically ill patients with novel coronavirus infectious disease (COVID-19) in China: a retrospective multicenter study. Intensive Care Medicine 2020; 46 (10): 1863–1872. doi: 10.1007/s00134-020-06211-2
9. Kellum JA, Lameire N, Aspelin P, Barsoum RS, Burdmann EA et al. Kidney disease: Improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney International Supplements 2012; 2 (1): 1–138. doi: 10.1038/kisup.2012.1
10. Yang X, Yu Y, Xu J, Shu H, Xia J et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respiratory Medicine 2020; 8 (5): 475–481. doi: 10.1016/S2213-2600(20)30079-5
11. Alhazzani W, Evans L, Alshamsi F, Møller MH, Ostermann M et al. Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First Update. Critical Care Medicine 2021; 49 (3): e219– e234. doi: 10.1097/CCM.0000000000004899
12. Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA et al. Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clinical Infectious Diseases 2016; 63 (5): e61–e111. doi: 10.1093/cid/ciw353
13. Simpson S, Kay FU, Abbara S, Bhalla S, Chung JH et al. Radiological Society of North America Expert Consensus Document on Reporting Chest CT Findings Related to COVID-19: Endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA. Radiology Cardiothoracic Imaging 2020; 2(2): e200152. doi: 10.1148/ ryct.2020200152
14. Chang Y-C, Yu C-J, Chang S-C, Galvin JR, Liu H-M et al. Pulmonary sequelae in convalescent patients after severe acute respiratory syndrome: evaluation with thin-section CT. Radiology 2005; 236 (3): 1067–1075. doi: 10.1148/ radiol.2363040958
15. Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo FX et al. Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. Journal of the American Medical Association 2020; 323 (16): 1612–1614. doi: 10.1001/ jama.2020.4326
16. Cummings MJ, Baldwin MR, Abrams D, Jacobson SD, Meyer BJ et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet 2020; 395 (10239): 1763–1770. doi: 10.1016/S0140-6736(20)31189-2
17. Wang Y, Lu X, Li Y, Chen H, Chen T et al. Clinical Course and Outcomes of 344 Intensive Care Patients with COVID-19. American Journal of Respiratory and Critical Care Medicine 2020; 201 (11): 1430-1434. doi: 10.1164/rccm.202003-0736LE
18. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. Journal of the American Medical Association 2020; 323 (20): 2052–2059. doi: 10.1001/ jama.2020.6775
19. Francone M, Iafrate F, Masci GM, Coco S, Cilia F et al. Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis. European Radiology 2020; 30 (12): 6808–6817. doi: 10.1007/s00330-020-07033-y
20. Saeed GA, Gaba W, Shah A, Al Helali AA, Raidullah E et al. Correlation between Chest CT Severity Scores and the Clinical Parameters of Adult Patients with COVID-19 Pneumonia. Radiology Research and Practice 2021; 2021: 6697677. doi: 10.1155/2021/6697677
21. Feng Z, Yu Q, Yao S, Luo L, Zhou W et al. Early prediction of disease progression in COVID-19 pneumonia patients with chest CT and clinical characteristics. Nature Communications 2020; 11 (1): 4968. doi: 10.1038/s41467-020-18786-x
22. Deng Y, Liu W, Liu K, Fang Y-Y, Shang J et al. Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: a retrospective study. Chinese Medical Journal 2020; 133 (11): 1261–1267. doi: 10.1097/ CM9.0000000000000824
23. Lansbury L, Lim B, Baskaran V, Lim WS. Co-infections in people with COVID-19: a systematic review and meta-analysis. The Journal of Infection 2020; 81 (2): 266–275. doi:10.1016/j. jinf.2020.05.046
24. Liu W, Zhou P, Chen K, Ye Z, Liu F et al. Efficacy and safety of antiviral treatment for COVID-19 from evidence in studies of SARS-CoV-2 and other acute viral infections: a systematic review and meta-analysis. Canadian Medical Association Journal 2020; 192 (27): E734–E744. doi: 10.1503/cmaj.200647
25. Horby P, Lim WS, Emberson JR, Mafham M, Bell JL et al. Dexamethasone in Hospitalized Patients with Covid-19. The New England Journal of Medicine 2021; 384 (8): 693–704. doi: 10.1056/NEJMoa2021436
26. Hasan SS, Capstick T, Ahmed R, Kow CS, Mazhar F et al. Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis. Expert Review of Respiratory Medicine 2020; 14 (11): 1149–1163. doi: 10.1080/17476348.2020.1804365
27. Sterne JAC, Murthy S, Diaz J V, Slutsky AS, Villar J et al. Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis. Journal of the American Medical Association 2020; 324 (13): 1330–1341. doi: 10.1001/ jama.2020.17023
28. van Paassen J, Vos JS, Hoekstra EM, Neumann KMI, Boot PC et al. Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes. Critical Care 2020; 24 (1): 696. doi: 10.1186/s13054-020-03400-9
29. Simonovich VA, Burgos Pratx LD, Scibona P, Beruto M V, Vallone MG et al. A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia. New England Journal of Medicine 2021; 384 (7): 619–629. doi: 10.1056/ NEJMoa2031304